PURPOSE: It is unknown whether alcohol intake is associated with the risk of lethal (metastatic or fatal) prostate cancer. We examine (1) whether alcohol intake among men at risk of prostate cancer is associated with diagnosis of lethal prostate cancer and (2) whether intake among men with nonmetastatic prostate cancer is associated with metastasis or death. METHODS: This prospective cohort study uses the Health Professionals Follow-Up Study (1986 to 2012). Our analysis of alcohol intake among men at risk of prostate cancer included 47,568 cancer-free men. Our analysis of alcohol intake among men with prostate cancer was restricted to 5,182 men diagnosed with nonmetastatic prostate cancer during follow-up. We examine the association of total alcohol, red and white wine, beer, and liquor with lethal prostate cancer and death. Multivariate Cox proportional hazards regression estimated hazard ratios (HRs) and 95% CIs. RESULTS: Alcohol drinkers had a lower risk of lethal prostate cancer (any v none: HR, 0.84 [95% CI, 0.71 to 0.99]) without a dose-response relationship. Total alcohol intake among patients with prostate cancer was not associated with progression to lethal prostate cancer (any v none: HR, 0.99 [95% CI, 0.57 to 1.72]), whereas moderate red wine intake was associated with a lower risk (any v none: HR, 0.50 [95% CI, 0.29 to 0.86]; P trend = .05). Compared with none, 15 to 30 g/d of total alcohol after prostate cancer diagnosis was associated with a lower risk of death (HR, 0.71 [95% CI, 0.50 to 1.00]), as was red wine (any v none: HR, 0.74 [95% CI, 0.57 to 0.97]; P trend = .007). CONCLUSION: Cancer-free men who consumed alcohol had a slightly lower risk of lethal prostate cancer compared with abstainers. Among men with prostate cancer, red wine was associated with a lower risk of progression to lethal disease. These observed associations merit additional study but provide assurance that moderate alcohol consumption is safe for patients with prostate cancer.
PURPOSE: It is unknown whether alcohol intake is associated with the risk of lethal (metastatic or fatal) prostate cancer. We examine (1) whether alcohol intake among men at risk of prostate cancer is associated with diagnosis of lethal prostate cancer and (2) whether intake among men with nonmetastatic prostate cancer is associated with metastasis or death. METHODS: This prospective cohort study uses the Health Professionals Follow-Up Study (1986 to 2012). Our analysis of alcohol intake among men at risk of prostate cancer included 47,568 cancer-free men. Our analysis of alcohol intake among men with prostate cancer was restricted to 5,182 men diagnosed with nonmetastatic prostate cancer during follow-up. We examine the association of total alcohol, red and white wine, beer, and liquor with lethal prostate cancer and death. Multivariate Cox proportional hazards regression estimated hazard ratios (HRs) and 95% CIs. RESULTS:Alcohol drinkers had a lower risk of lethal prostate cancer (any v none: HR, 0.84 [95% CI, 0.71 to 0.99]) without a dose-response relationship. Total alcohol intake among patients with prostate cancer was not associated with progression to lethal prostate cancer (any v none: HR, 0.99 [95% CI, 0.57 to 1.72]), whereas moderate red wine intake was associated with a lower risk (any v none: HR, 0.50 [95% CI, 0.29 to 0.86]; P trend = .05). Compared with none, 15 to 30 g/d of total alcohol after prostate cancer diagnosis was associated with a lower risk of death (HR, 0.71 [95% CI, 0.50 to 1.00]), as was red wine (any v none: HR, 0.74 [95% CI, 0.57 to 0.97]; P trend = .007). CONCLUSION:Cancer-free men who consumed alcohol had a slightly lower risk of lethal prostate cancer compared with abstainers. Among men with prostate cancer, red wine was associated with a lower risk of progression to lethal disease. These observed associations merit additional study but provide assurance that moderate alcohol consumption is safe for patients with prostate cancer.
Authors: Barbra A Dickerman; Sarah Coseo Markt; Markku Koskenvuo; Eero Pukkala; Lorelei A Mucci; Jaakko Kaprio Journal: Cancer Causes Control Date: 2016-06-28 Impact factor: 2.506
Authors: Siobhan Sutcliffe; Edward Giovannucci; Michael F Leitzmann; Eric B Rimm; Meir J Stampfer; Walter C Willett; Elizabeth A Platz Journal: Int J Cancer Date: 2007-04-01 Impact factor: 7.396
Authors: N P Papa; R J MacInnis; H Jayasekara; D R English; D Bolton; I D Davis; N Lawrentschuk; J L Millar; J Pedersen; G Severi; M C Southey; J L Hopper; G G Giles Journal: Prostate Cancer Prostatic Dis Date: 2017-04-18 Impact factor: 5.554
Authors: Zsuzsanna Horvath; Sybille Marihart-Fazekas; Philipp Saiko; Michael Grusch; Mehmet Ozsüy; Mike Harik; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Bob Djavan; Thomas Szekeres Journal: Anticancer Res Date: 2007 Sep-Oct Impact factor: 2.480
Authors: Wolfgang Streicher; Manuel Luedeke; Anca Azoitei; Friedemann Zengerling; Alexander Herweg; Felicitas Genze; Mark G Schrader; Andres J Schrader; Marcus V Cronauer Journal: PLoS One Date: 2014-06-02 Impact factor: 3.240
Authors: Danyon Anderson; Abrahim N Razzak; Matthew McDonald; David Cao; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits Journal: Health Psychol Res Date: 2022-08-20
Authors: June M Chan; Stacey A Kenfield; Rebecca E Graff; Crystal S Langlais; Erin L Van Blarigan; Claire H Pernar; Meir J Stampfer; Edward L Giovannucci; Lorelei A Mucci Journal: Br J Cancer Date: 2022-08-26 Impact factor: 9.075
Authors: Catherine R Marinac; Dong Hoon Lee; Graham A Colditz; Timothy R Rebbeck; Bernard Rosner; Mark Bustoros; Irene M Ghobrial; Brenda M Birmann Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-12-03 Impact factor: 4.090
Authors: Hui-Yi Lin; Tung-Sung Tseng; Xinnan Wang; Zhide Fang; Arnold H Zea; Liang Wang; Julio Pow-Sang; Catherine M Tangen; Phyllis J Goodman; Alicja Wolk; Niclas Håkansson; Manolis Kogevinas; Javier Llorca; Hermann Brenner; Ben Schöttker; Jose Esteban Castelao; Manuela Gago-Dominguez; Marija Gamulin; Davor Lessel; Frank Claessens; Steven Joniau; Jong Y Park Journal: Cancers (Basel) Date: 2022-04-14 Impact factor: 6.575
Authors: Dong Hoon Lee; Teresa T Fung; Fred K Tabung; Catherine R Marinac; Elizabeth E Devore; Bernard A Rosner; Irene M Ghobrial; Graham A Colditz; Edward L Giovannucci; Brenda M Birmann Journal: Int J Cancer Date: 2020-02-28 Impact factor: 7.396
Authors: Crystal S Langlais; Rebecca E Graff; Erin L Van Blarigan; Nynikka R Palmer; Samuel L Washington; June M Chan; Stacey A Kenfield Journal: Curr Oncol Rep Date: 2021-03-10 Impact factor: 5.075